TissGeneSummary for MT1H |
Gene summary |
Basic gene information | Gene symbol | MT1H |
Gene name | metallothionein 1H | |
Synonyms | MT-0|MT-1H|MT-IH|MT1 | |
Cytomap | UCSC genome browser: 16q13 | |
Type of gene | protein-coding | |
RefGenes | NM_005951.2, | |
Description | metallothionein-0metallothionein-1Hmetallothionein-IH | |
Modification date | 20141207 | |
dbXrefs | MIM : 156354 | |
HGNC : HGNC | ||
Ensembl : ENSG00000205358 | ||
HPRD : 01128 | ||
Vega : OTTHUMG00000133283 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MT1H | |
BioGPS: 4496 | ||
Pathway | NCI Pathway Interaction Database: MT1H | |
KEGG: MT1H | ||
REACTOME: MT1H | ||
Pathway Commons: MT1H | ||
Context | iHOP: MT1H | |
ligand binding site mutation search in PubMed: MT1H | ||
UCL Cancer Institute: MT1H | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | LiverEye | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHCUVM | |
Reference showing the relevant tissue of MT1H | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for MT1H |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUAD | -1.152489176 | -2.795977107 | 1.643487931 | 1.45E-07 | 5.54E-07 |
LIHC | -1.023757728 | 6.961830272 | -7.985588 | 2.40E-25 | 5.33E-23 |
LUSC | -0.899746512 | -2.467256316 | 1.567509804 | 1.86E-05 | 4.13E-05 |
KIRC | -1.417314894 | 4.369319828 | -5.786634722 | 4.01E-23 | 4.08E-22 |
KICH | -2.751081728 | 4.700514272 | -7.451596 | 2.29E-14 | 3.80E-13 |
KIRP | -2.424876353 | 5.370420522 | -7.795296875 | 3.98E-20 | 2.62E-18 |
THCA | 0.658014272 | 4.842719357 | -4.184705085 | 2.62E-12 | 2.15E-11 |
COAD | 0.245795042 | 4.406733503 | -4.160938462 | 1.30E-09 | 1.42E-08 |
BLCA | -1.746238359 | -3.403369938 | 1.657131579 | 0.00086 | 0.006230098 |
Top |
TissGene-miRNA for MT1H |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for MT1H |
TissGeneSNV for MT1H |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E8K | BLCA | 2 |
p.K23R | KIRC | 1 |
p.K31E | ESCA | 1 |
p.S28F | SKCM | 1 |
p.A14T | CESC | 1 |
p.P3L | SKCM | 1 |
p.C13R | HNSC | 1 |
p.A53G | LUAD | 1 |
p.S32R | PAAD | 1 |
p.C48F | KIRC | 1 |
p.G11V | CESC | 1 |
p.S32C | LUAD | 1 |
p.P38T | CESC | 1 |
Top |
TissGeneCNV for MT1H |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for MT1H |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for MT1H |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for MT1H |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for MT1H |
TissGeneDrug for MT1H |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for MT1H |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0006142 | Malignant neoplasm of breast | 5 | BeFree |
umls:C0678222 | Breast Carcinoma | 5 | BeFree |
umls:C0339573 | Glaucoma, Primary Open Angle | 4 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 2 | BeFree |
umls:C1458155 | Mammary Neoplasms | 2 | BeFree |
umls:C0005684 | Malignant neoplasm of urinary bladder | 1 | BeFree |
umls:C0007131 | Non-Small Cell Lung Carcinoma | 1 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 1 | BeFree |
umls:C0009375 | Colonic Neoplasms | 1 | BeFree |
umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | BeFree |
umls:C0022336 | Creutzfeldt-Jakob disease | 1 | BeFree |
umls:C0041848 | Unspecified idiopathic peripheral neuropathy | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
umls:C0279000 | Liver and Intrahepatic Biliary Tract Carcinoma | 1 | BeFree |
umls:C0345904 | Malignant neoplasm of liver | 1 | BeFree |
umls:C0410702 | Adolescent idiopathic scoliosis | 1 | BeFree |
umls:C0596263 | Carcinogenesis | 1 | BeFree |
umls:C0684249 | Carcinoma of lung | 1 | BeFree |
umls:C0699885 | Carcinoma of bladder | 1 | BeFree |
umls:C1862939 | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1 | BeFree |
umls:C2239176 | Liver carcinoma | 1 | BeFree |
umls:C3714542 | Lymphoma, Diffuse | 1 | BeFree |